-
Junshi Biosciences launches a "patent challenge" against Novartis: generic drugs and original pharmaceutical companies engage in a fiercer competition
2025-05-07In recent years, disputes over innovative drug patents have continuedly happened. Recently, CNIPA issued an oral examination announcement stating that the patent of Alnylam Pharmaceuticals, Inc. with the application number "2013800639305" and the invention name "PCSK9 iRNA composition and its method -
CNIPA and EAPO extend PPH pilot program
2025-05-07The China National Intellectual Property Administration (CNIPA) and the Eurasian Patent Organization (EAPO) have jointly decided to extend their Patent prosecution highway (PPH) pilot program for an indefinite time period from April 1, 2023.Benefiting from the addition of PCT-PPH to the existing PPH -
EPO releases 2022 patent index: Huawei, OPPO, Tencent, BOE, and other 9 companies are shortlisted for TOP50
2025-05-07On March 28, 2023, the European Patent Office (EPO) issued the 2022 Patent Index (Patent Index 2022). According to EPO statistics, over 193,000 patent applications were filed with the European Patent Office in 2022, an increase of 2.5%, which sets a new record.Growth in EPO patent applications in 20 -
Dawei released the "2021 China Final Patentee Innovation Ranking List" On World Intellectual Property Day
2025-05-07On the basis of the ranking list, the State Grid ranks first, with 53,582 patents granted by a large margin ahead of other entities; Huawei also comes out in front, maintaining a clear advantage in innovation, ranking second with 46,602 patents granted. State Grid and Huawei are the leading innovati -
Bulletin of the NCAC on National Copyright Registration in 2022
2025-05-07In 2022, the total number of copyright registrations in China reached 6,353,144, a year-on-year increase of 1.42%.According to the statistics of copyright registration information of provinces, autonomous regions, and municipalities directly under the Central Government and the China Copyright Prote